International life sciences company merger

Brandwood CKC, formed in 2019 following the merger of two leading Australian consulting firms, offers a range of regulatory, technical, and commercial services for developers, manufacturers and suppliers of medical devices, diagnostics, and pharmaceutical products.

Piper Alderman advised Brandwood CKC on its merger with international life sciences consultancy PharmaLex Group. After the merger, Brandwood CKC became part of the privately-owned PharmaLex Group, establishing an Australian presence for PharmaLex.

Piper Alderman’s team assisted the board and shareholders of Brandwood CKC with negotiating and implementing the transaction documents and planning for post-completion operations. The team also advised on employment aspects and leasing negotiations of the merger.

Brandwood CKC managing director Grant Bennett said:

“The merger allows us to expand the range and geographical reach of services we can provide our clients, as well as supporting PharmaLex by providing global expertise in the medical device and diagnostic sectors.

We have always provided solid experience-backed support to clients, including access into Europe and the USA.  However, having the support and access of PharmaLex in these regions, takes us to the next level.

The opportunity the merger provides to our clients and international markets is a huge value add, and the support provided by Piper Alderman was invaluable to ensuring the transaction ran seamlessly.”